GMO TRUST
NSAR-A, EX-27, 2000-10-27
Previous: GMO TRUST, NSAR-A, EX-27, 2000-10-27
Next: GMO TRUST, NSAR-A, EX-27, 2000-10-27



<TABLE> <S> <C>

<ARTICLE> 6
<LEGEND>
This schedule contains summary financial
information extracted from GMO Trust, form
N-SAR for the period ended August 31, 2000
and is qualified in its entirety by reference
to such financial statements.
</LEGEND>
<SERIES>
   <NUMBER> 263
   <NAME> GMO Global Balanced Allocation Fund, Class III

<S>                             <C>
<PERIOD-TYPE>                                         6-MOS
<FISCAL-YEAR-END>                               FEB-28-2001
<PERIOD-END>                                    AUG-31-2000
<INVESTMENTS-AT-COST>                          131,349,547
<INVESTMENTS-AT-VALUE>                         127,648,516
<RECEIVABLES>                                        3,689
<ASSETS-OTHER>                                           0
<OTHER-ITEMS-ASSETS>                                     0
<TOTAL-ASSETS>                                 127,652,205
<PAYABLE-FOR-SECURITIES>                                 0
<SENIOR-LONG-TERM-DEBT>                                  0
<OTHER-ITEMS-LIABILITIES>                           14,301
<TOTAL-LIABILITIES>                                 14,301
<SENIOR-EQUITY>                                          0
<PAID-IN-CAPITAL-COMMON>                       128,292,720
<SHARES-COMMON-STOCK>                           11,179,672
<SHARES-COMMON-PRIOR>                           11,050,953
<ACCUMULATED-NII-CURRENT>                        2,022,439
<OVERDISTRIBUTION-NII>                                   0
<ACCUMULATED-NET-GAINS>                          1,023,776
<OVERDISTRIBUTION-GAINS>                                 0
<ACCUM-APPREC-OR-DEPREC>                        (3,701,031)
<NET-ASSETS>                                   127,637,904
<DIVIDEND-INCOME>                                2,025,357
<INTEREST-INCOME>                                      303
<OTHER-INCOME>                                           0
<EXPENSES-NET>                                           0
<NET-INVESTMENT-INCOME>                          2,025,660
<REALIZED-GAINS-CURRENT>                         2,955,897
<APPREC-INCREASE-CURRENT>                        4,095,491
<NET-CHANGE-FROM-OPS>                            9,077,048
<EQUALIZATION>                                           0
<DISTRIBUTIONS-OF-INCOME>                       (1,385,582)
<DISTRIBUTIONS-OF-GAINS>                          (292,887)
<DISTRIBUTIONS-OTHER>                                    0
<NUMBER-OF-SHARES-SOLD>                            777,591
<NUMBER-OF-SHARES-REDEEMED>                       (783,669)
<SHARES-REINVESTED>                                134,797
<NET-CHANGE-IN-ASSETS>                           8,563,315
<ACCUMULATED-NII-PRIOR>                          1,382,361
<ACCUMULATED-GAINS-PRIOR>                                0
<OVERDISTRIB-NII-PRIOR>                                  0
<OVERDIST-NET-GAINS-PRIOR>                      (1,639,234)
<GROSS-ADVISORY-FEES>                                    0
<INTEREST-EXPENSE>                                       0
<GROSS-EXPENSE>                                     21,712
<AVERAGE-NET-ASSETS>                           123,649,853
<PER-SHARE-NAV-BEGIN>                                10.78
<PER-SHARE-NII>                                       0.18
<PER-SHARE-GAIN-APPREC>                               0.61
<PER-SHARE-DIVIDEND>                                 (0.12)
<PER-SHARE-DISTRIBUTIONS>                            (0.03)
<RETURNS-OF-CAPITAL>                                  0.00
<PER-SHARE-NAV-END>                                  11.42
<EXPENSE-RATIO>                                       0.00


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission